Contemporary issues in toxicology - The role of metabonomics in toxicology and its evaluation by the COMET project

被引:317
作者
Lindon, JC
Nicholson, JK
Holmes, E
Antti, H
Bollard, ME
Keun, H
Beckonert, O
Ebbels, TM
Reilly, MD
Robertson, D
Stevens, GJ
Luke, P
Breau, AP
Cantor, GH
Bible, RH
Niederhauser, U
Senn, H
Schlotterbeck, G
Sidelmann, UG
Laursen, SM
Tymiak, A
Car, BD
Lehman-McKeeman, L
Colet, JM
Loukaci, A
Thomas, C
机构
[1] Univ London Imperial Coll Sci Technol & Med, Fac Med, Biol Chem Biomed Sci Div, London SW7 2AZ, England
[2] Pfizer Global R&D, Ann Arbor, MI 48105 USA
[3] Pfizer Global R&D, La Jolla, CA 92121 USA
[4] Pfizer Global R&D, Sandwich CT13 9NJ, Kent, England
[5] Pharmacia Corp, Skokie, IL 60077 USA
[6] Pharmacia Corp, Kalamazoo, MI 49007 USA
[7] Hoffmann La Roche Ag, CH-4070 Basel, Switzerland
[8] Novo Nordisk, DK-2760 Malov, Denmark
[9] Bristol Myers Squibb Co, Princeton, NJ 08543 USA
[10] Eli Lilly & Co, Lilly Dev Ctr SA, Lilly Res Labs, B-1348 Louvain, Belgium
关键词
metabonomics; toxin; pharmaceutical; NMR; chemometrics; expert system;
D O I
10.1016/S0041-008X(02)00079-0
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The role that metabonomics has in the evaluation of xenobiotic toxicity studies is presented here together with a brief summary of published studies. To provide a comprehensive assessment of this approach, the Consortium for Metabonomic Toxicology (COMET) has been formed between six pharmaceutical companies and Imperial College of Science, Technology and Medicine (IC), London, UK. The objective of this group is to define methodologies and to apply metabonomic data generated using H-1 NMR spectroscopy of urine and blood serum for preclinical toxicological screening of candidate drugs. This is being achieved by generating databases of results for a wide range of model toxins which serve as the raw material for computer-based expert systems for toxicity prediction. The project progress on the generation of comprehensive metabonomic databases and multivariate statistical models for prediction of toxicity, initially for Ever and kidney toxicity in the rat and mouse, is reported. Additionally, both the analytical and biological variation which might arise through the use of metabonomics has been evaluated. An evaluation of intersite NMR analytical reproducibility has revealed a high degree of robustness. Second, a detailed comparison has been made of the ability of the six companies to provide consistent urine and serum samples using a study of the toxicity of hydrazine at two doses in the male rat, this study showing a high degree of consistency between samples from the various companies in terms of spectral patterns and biochemical composition. Differences between samples from the various companies were small compared to the biochemical effects of the toxin. A metabonomic model has been constructed for urine from control rats, enabling identification of outlier samples and the metabolic reasons for the deviation. Building on this success, and with the completion of studies on approximately 80 model toxins, first expert systems for prediction of liver and kidney toxicity have been generated. (C) 2003 Elsevier Science (USA). All rights reserved.
引用
收藏
页码:137 / 146
页数:10
相关论文
共 47 条
  • [1] Toxicology and genetic toxicology in the new era of "toxicogenomics": impact of "-omics" technologies
    Aardema, MJ
    MacGregor, JT
    [J]. MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS, 2002, 499 (01) : 13 - 25
  • [2] AMENTA JS, 1962, LAB INVEST, V11, P956
  • [3] CEPHALORIDINE-INDUCED NEPHROTOXICITY IN THE FISCHER-344 RAT - PROTON NMR SPECTROSCOPIC STUDIES OF URINE AND PLASMA IN RELATION TO CONVENTIONAL CLINICAL CHEMICAL AND HISTOPATHOLOGICAL ASSESSMENTS OF NEPHRONAL DAMAGE
    ANTHONY, ML
    GARTLAND, KPR
    BEDDELL, CR
    LINDON, JC
    NICHOLSON, JK
    [J]. ARCHIVES OF TOXICOLOGY, 1992, 66 (08) : 525 - 537
  • [4] ANTHONY ML, 1994, MOL PHARMACOL, V46, P199
  • [5] CLASSIFICATION OF TOXIN-INDUCED CHANGES IN H-1-NMR SPECTRA OF URINE USING AN ARTIFICIAL NEURAL-NETWORK
    ANTHONY, ML
    ROSE, VS
    NICHOLSON, JK
    LINDON, JC
    [J]. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 1995, 13 (03) : 205 - 211
  • [6] ANTHONY ML, 1994, ARCH TOXICOL, V68, P43
  • [7] Batch statistical processing of 1H NMR-derived urinary spectral data
    Antti, H
    Bollard, ME
    Ebbels, T
    Keun, H
    Lindon, JC
    Nicholson, JK
    Holmes, E
    [J]. JOURNAL OF CHEMOMETRICS, 2002, 16 (8-10) : 461 - 468
  • [8] Nuclear magnetic resonance spectroscopic and principal components analysis investigations into biochemical effects of three model hepatotoxins
    Beckwith-Hall, BM
    Nicholson, JK
    Nicholls, AW
    Foxall, PJD
    Lindon, JC
    Connor, SC
    Abdi, M
    Connelly, J
    Holmes, E
    [J]. CHEMICAL RESEARCH IN TOXICOLOGY, 1998, 11 (04) : 260 - 272
  • [9] An NMR-based metabonomic approach to the investigation of coelomic fluid biochemistry in earthworms under toxic stress
    Bundy, JG
    Osborn, D
    Weeks, JM
    Lindon, JC
    Nicholson, JK
    [J]. FEBS LETTERS, 2001, 500 (1-2) : 31 - 35
  • [10] Enhanced resolution of proton NMR spectra of malignant lymph nodes using magic-angle spinning
    Cheng, LL
    Lean, CL
    Bogdanova, A
    Wright, SC
    Ackerman, JL
    Brady, TJ
    Garrido, L
    [J]. MAGNETIC RESONANCE IN MEDICINE, 1996, 36 (05) : 653 - 658